[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 17, Issue 3 (6-2019) ::
Int J Radiat Res 2019, 17(3): 409-414 Back to browse issues page
The impact of benign prostatic hyperplasia on bladder volume in radiotherapy of prostate cancer
H. Jang, J.G. Baek, S.Y. Kwon, K.S. Lee, Y.T. Oh
Department of Radiation Oncology, Dongguk University College of Medicine, Gyeongju, Korea , opencagejhs@gmail.com
Abstract:   (2541 Views)
Background: Benign prostatic hyperplasia (BPH) is a common disease among older men and many patients with prostate cancer (PC) also have BPH. External beam radiation therapy (EBRT) is one of the important treatments for PC, nevertheless, few studies have analyzed the effect of BPH on EBRT. We tried to know the risk of bladder toxicity by analyzing the bladder volume variability in patients with BPH. Materials and Methods: Changes in prostate location with respect to the presence of BPH and bladder volume by bladder zone were analyzed. Dosimetric parameters of prostate and bladder were analyzed using planning computed tomography (CT) scans in 20 patients with PC. Three planning CTs were performed on each patient during RT. Maximum bladder volume variations were calculated using the three planning CT scans and volumes of upper and lower zones were compared. Results: Mean upper and lower bladder volume ratio was 0.85 and 0.15, and mean maximum differences in bladder volumes for the three CTs were 97.33 cc and 10.36 cc for upper and lower bladders, respectively (p < 0.001). Prostate size and location with respect to prostate upper margin showed a moderate linear correlation (r = 0.567, p = 0.009). Prostate superior margins of patients with or without BPH were located at mean distances of 3 mm above and 4.8 mm below the superior border of pubic bones, respectively (p = 0.019). Conclusion: The prostates of patients with BPH were more likely to be located in the upper bladder zone, which exhibited greater bladder volume variability. This implies that the clinical target volume of EBRT is located in an unstable bladder zone, which would decrease treatment accuracy and increase treatment-related bladder toxicity. The further clinical study is required to analyze the relation between BPH and the severity of RT-induced bladder toxicity.
Keywords: prostate cancer, benign prostatic hyperplasia, radiotherapy, bladder toxicity.
Full-Text [PDF 1467 kb]   (722 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jang H, Baek J, Kwon S, Lee K, Oh Y. The impact of benign prostatic hyperplasia on bladder volume in radiotherapy of prostate cancer. Int J Radiat Res. 2019; 17 (3) :409-414
URL: http://ijrr.com/article-1-2582-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 17, Issue 3 (6-2019) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.04 seconds with 32 queries by YEKTAWEB 4419